The Committee for Human Use (CHMP) of the EMEA has recommended in its meeting of February 2011, allowing Methylthioninchlorid.
Methylthioninchlorid (Methylthioniniumchlorid Proveblue, Provepharm SAS) is an acute symptomatic therapy can be used by medication or chemical-induced methemoglobinemia.
Source:
Press release of 18 EMA February 2011
0 comments:
Post a Comment